Medicure (MCUJF) Income from Continuing Operations (2009 - 2026)
Medicure's (MCUJF) quarterly Income from Continuing Operations came in at 296057.51 in Q1 2026, down 168.74% year-on-year from 430694.38 in Q1 2025, and up 95.72% quarter-over-quarter from 6923468.06 in Q4 2025.
Medicure (MCUJF) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Medicure's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 296057.51 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 168.74% year-over-year to 296057.51 in Q1 2026; TTM through Mar 2026 was 8801174.06, a 2368.83% decrease from a year earlier, with the FY2025 full-year figure at 5079474.98, down 569.33% from the prior year.
- Income from Continuing Operations climbed to 296057.51 in Q1 2026 per MCUJF's latest filing, from 6923468.06 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 3974512.36 in Q4 2022 and bottomed at 6923468.06 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 83858.79 (2024), against an average of 182943.88.
- Across the five-year window, Income from Continuing Operations jumped 695.55% in 2024 and slumped 1648.95% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 3974512.36 in 2022, then tumbled by 130.12% to 1197292.91 in 2023, then jumped by 66.94% to 395864.57 in 2024, then slumped by 1648.95% to 6923468.06 in 2025, then jumped by 95.72% to 296057.51 in 2026.
- Per Business Quant, the three latest MCUJF Income from Continuing Operations figures stand at 296057.51 (Q1 2026), 6923468.06 (Q4 2025), and 1014382.46 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -296,057.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -296,057.51 |
| Dec 31, 2025 | -6.92 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -567,266.02 |
| Mar 31, 2025 | 430,694.38 |
| Dec 31, 2024 | -395,864.57 |
| Sep 30, 2024 | 498,476.32 |
| Jun 30, 2024 | -889,798.05 |
| Mar 31, 2024 | 83,858.79 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | 62,658.16 |
| Jun 30, 2023 | 188,346.47 |
| Mar 31, 2023 | 201,197.41 |
| Dec 31, 2022 | 3.97 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 568,646.97 |
| Mar 31, 2022 | 280,263.77 |
| Sep 30, 2021 | -2.04 Mn |
| Jun 30, 2021 | 407,577.11 |
| Mar 31, 2021 | 828,023.88 |